Shattuck Labs, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:STTK) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 91.05 M77.17 M64.37 M100.33 M91.03 M102.12 M 負債合計 11.42 M9.58 M7.35 M7.09 M8.64 M6.29 M 純資産合計 79.63 M67.59 M57.02 M93.24 M82.39 M95.83 M 負債および純資産合計 91.05 M77.17 M64.37 M100.33 M91.03 M102.12 M 有利子負債合計 —————— 純負債 ——————

ニュース

Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation (NASDAQ:STTK)

Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK)

TD Cowen、薬剤データを受けてShattuck Labsを買い推奨で維持

Shattuck Labs stock maintained at Buy by TD Cowen on drug data

パイパー・サンドラー、シャタック・ラボの株式を「オーバーウェイト」で新規カバー開始

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

H.C. ワインライト、シャタック・ラボの評価を「買い」に引き上げ

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript